-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Needham Adjusts Price Target on Pacira BioSciences to $63 From $66, Maintains Buy Rating

--Needham Adjusts Price Target on Pacira BioSciences to $63 From $66, Maintains Buy Rating

MT Newswires · 01/06/2023 05:29